相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components Findings from the Jackson Heart Study
Solomon K. Musani et al.
DIABETES CARE (2013)
Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study
E. M. Camacho et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis
Giovanni Corona et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1
Se Won Kim et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Effects of Pravastatin and Atorvastatin on HDL Cholesterol and Glucose Metabolism in Patients with Dyslipidemia and Glucose Intolerance: The PRAT Study
Jun Sasaki et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2013)
Effects of Testosterone and Progressive Resistance Exercise in Healthy, Highly Functioning Older Men With Low-Normal Testosterone Levels
Kerry L. Hildreth et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Sex Steroid Hormone Levels and Body Composition in Men
Margaret A. Gates et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Testosterone: a vascular hormone in health and disease
Daniel M. Kelly et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Testosterone: a metabolic hormone in health and disease
Daniel M. Kelly et al.
JOURNAL OF ENDOCRINOLOGY (2013)
IPASS: A Study on the Tolerability and Effectiveness of Injectable Testosterone Undecanoate for the Treatment of Male Hypogonadism in a Worldwide Sample of 1,438 Men
Michael Zitzmann et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
Preethi M. Rao et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Long-Term Treatment of Hypogonadal Men with Testosterone Produces Substantial and Sustained Weight Loss
Farid Saad et al.
OBESITY (2013)
Effect of the Mediterranean Diet with and Without Weight Loss on Markers of Inflammation in Men with Metabolic Syndrome
Caroline Richard et al.
OBESITY (2013)
The effect of androgens on lipids
Anne K. Monroe et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2013)
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
Jennifer G. Robinson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study
Sonja Firtser et al.
ATHEROSCLEROSIS (2012)
HDL quality in atherosclerosis: can ratios between apolipoproteins of HDL be used effectively to indicate risk of premature myocardial infarction?
Kyriakos E. Kypreos
CLINICAL LIPIDOLOGY (2012)
Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
Farid Saad
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial
Camilla M. Hoyos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Goodbye Androgen Hypothesis, Hello Saturation Model
Abraham Morgentaler
EUROPEAN UROLOGY (2012)
Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial
Roberto L. Muller et al.
EUROPEAN UROLOGY (2012)
Impact of testosterone on body fat composition
Chiara De Maddalena et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Testosterone Treatment and Mortality in Men with Low Testosterone Levels
Molly M. Shores et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements
Elena Maneschi et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
Katya B. Rubinow et al.
JOURNAL OF LIPID RESEARCH (2012)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men
Katya B. Rubinow et al.
STEROIDS (2012)
Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency: A Review
Farid Saad et al.
CURRENT DIABETES REVIEWS (2012)
Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease Patients
Silvia Bleda et al.
CHOLESTEROL (2012)
Testosterone Deficiency
Abdulmaged M. Traish et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Testosterone and cardiovascular disease: An old idea with modern clinical implications
Abdulmaged M. Traish et al.
ATHEROSCLEROSIS (2011)
Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes
R. D. Stanworth et al.
CLINICAL ENDOCRINOLOGY (2011)
Associations of endogenous testosterone and SHBG with glycated haemoglobin in middle-aged and older men
Judith S. Brand et al.
CLINICAL ENDOCRINOLOGY (2011)
Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy
E. J. Hamilton et al.
CLINICAL ENDOCRINOLOGY (2011)
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
T. Hugh Jones et al.
DIABETES CARE (2011)
Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
Christina Wang et al.
DIABETES CARE (2011)
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
Giovanni Corona et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies
Judith S. Brand et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
Associations of endogenous testosterone and lipid profiles in middle-aged to older Taiwanese men
B-P Jiann et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2011)
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
Andre B. Araujo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Reference Ranges for Testosterone in Men Generated Using Liquid Chromatography Tandem Mass Spectrometry in a Community-Based Sample of Healthy Nonobese Young Men in the Framingham Heart Study and Applied to Three Geographically Distinct Cohorts
Shalender Bhasin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Body Mass Index Regulates Hypogonadism-Associated CV Risk: Results from a Cohort of Subjects with Erectile Dysfunction
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Testosterone and Metabolic Syndrome: A Meta-Analysis Study
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2011)
High Serum Testosterone Is Associated With Reduced Risk of Cardiovascular Events in Elderly Men The MrOS (Osteoporotic Fractures in Men) Study in Sweden
Claes Ohlsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)
Rajib K. Bhattacharya et al.
BMC ENDOCRINE DISORDERS (2011)
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study
Svetlana Y. Kalinchenko et al.
CLINICAL ENDOCRINOLOGY (2010)
Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women
Karine Blouin et al.
CLINICAL ENDOCRINOLOGY (2010)
Testosterone Concentrations in Diabetic and Nondiabetic Obese Men
Sandeep Dhindsa et al.
DIABETES CARE (2010)
Association of Testosterone and Sex Hormone-Binding Globulin With Metabolic Syndrome and Insulin Resistance in Men
Chaoyang Li et al.
DIABETES CARE (2010)
Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay
Kevin Niswender
DIABETES OBESITY & METABOLISM (2010)
Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled Study
Upendram Srinivas-Shankar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome
A. Aversa et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2010)
Effects of Testosterone Undecanoate on Cardiovascular Risk Factors and Atherosclerosis in Middle-Aged Men with Late-Onset Hypogonadism and Metabolic Syndrome: Results from a 24-month, Randomized, Double-Blind, Placebo-Controlled Study
Antonio Aversa et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Treatment of 161 Men with Symptomatic Late Onset Hypogonadism with Long-Acting Parenteral Testosterone Undecanoate: Effects on Body Composition, Lipids, and Psychosexual Complaints
Sompol Permpongkosol et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
T. Hugh Jones
JOURNAL OF DIABETES (2010)
Testosterone and the metabolic syndrome
Vakkat Muraleedharan et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2010)
Serum Alanine Aminotransferase, Metabolic Syndrome, and Cardiovascular Disease in an Australian Population
John K. Olynyk et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Prediction of Metabolic Syndrome by Low Serum Testosterone Levels in Men Results From the Study of Health in Pomerania
Robin Haring et al.
DIABETES (2009)
Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth
Abraham Morgentaler et al.
EUROPEAN UROLOGY (2009)
The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction
G. Corona et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2009)
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Abdulmaged M. Traish et al.
JOURNAL OF ANDROLOGY (2009)
The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction
Abdulmaged M. Traish et al.
JOURNAL OF ANDROLOGY (2009)
Fifty-two-Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabetes and Subnormal Plasma Testosterone
Armin E. Heufelder et al.
JOURNAL OF ANDROLOGY (2009)
The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
Abdulmaged M. Traish et al.
JOURNAL OF ANDROLOGY (2009)
Androgen metabolism in adipose tissue: Recent advances
Karine Blouin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Androgen deficiency and atherosclerosis: The lipid link
Abdulmaged M. Traish et al.
VASCULAR PHARMACOLOGY (2009)
Endogenous testosterone and serum lipids in middle-aged men
Juuso I. Makinen et al.
ATHEROSCLEROSIS (2008)
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Wolfram Goessling et al.
GASTROENTEROLOGY (2008)
The risk of metabolic syndrome according to the high-sensitivity C-reactive protein in apparently healthy Koreans
Chan-Hee Jung et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men - A randomized controlled trial
Marielle H. Emmelot-Vonk et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men
C. A. Allan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Low serum testosterone in men is inversely associated with non-fasting serum triglycerides:: The Tromso study
Ingvild Agledahl et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels
Ingvild Agledahl et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism
Maria A. Yialamas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men
Michael Zitzmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Aging, androgens, and the metabolic syndrome in a longitudinal study of aging
Annabelle Rodriguez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes
D. Kapoor et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Androgens and diabetes in men - Results from the Third National Health and Nutrition Examination Survey (NHANES III)
Elizabeth Selvin et al.
DIABETES CARE (2007)
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
D. Kapoor et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Sex differences of endogenous sex hormones and risk of type 2 diabetes - A systematic review and meta-analysis
EL Ding et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men
V Kupelian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic
G Corona et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2006)
Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors
R Singh et al.
ENDOCRINOLOGY (2006)
Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis
AM Isidori et al.
CLINICAL ENDOCRINOLOGY (2005)
Serum testosterone levels and arterial blood pressure in the elderly
R Fogari et al.
HYPERTENSION RESEARCH (2005)
Usefulness of total cholesterol/HDL-cholesterol ratio in the management of diabetic dyslipidaemia
JA Gimeno-Orna et al.
DIABETIC MEDICINE (2005)
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men
DE Laaksonen et al.
DIABETES CARE (2004)
The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men
CJ Malkin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study
J Svartberg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
PM Ridker et al.
CIRCULATION (2004)
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes
S Dhindsa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia
F Dockery et al.
CLINICAL SCIENCE (2003)
Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men
I Van Pottelbergh et al.
ATHEROSCLEROSIS (2003)
Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males
W Barud et al.
ATHEROSCLEROSIS (2002)
Sex hormones and hypertension
RK Dubey et al.
CARDIOVASCULAR RESEARCH (2002)
Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study
JY Oh et al.
DIABETES CARE (2002)
Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men -: The Quebec Cardiovascular Study
I Lemieux et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone - A 3-month randomized placebo-controlled trial
D Simon et al.
DIABETES CARE (2001)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Gender differences in the regulation of blood pressure
JF Reckelhoff
HYPERTENSION (2001)
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men - Prospective results from the Massachusetts Male Aging Study
RK Stellato et al.
DIABETES CARE (2000)
Primary care: Evaluation of abnormal liver-enzyme results in asymptomatic patients.
DS Pratt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
